Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity - PubMed (original) (raw)
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
C A Matteoni et al. Gastroenterology. 1999 Jun.
Abstract
Background & aims: The spectrum of nonalcoholic fatty liver disease ranges from fatty liver alone to nonalcoholic steatohepatitis. Most previous studies have short follow-up and have not carefully delineated different histological types when determining clinical outcomes. The aim of this study was to compare clinical characteristics and outcomes of patients with different types of nonalcoholic fatty liver.
Methods: All liver biopsy specimens from 1979 to 1987 with fat accumulation were assessed for inflammation, ballooning degeneration, Mallory hyaline, and fibrosis. Biopsy specimens were also assessed for histological iron and hepatitis C RNA. Outcomes were cirrhosis, mortality, and liver-related mortality.
Results: Of 772 liver biopsy specimens, complete data were available in 132 patients. Fatty liver (type 1) did not differ from the other three types combined with respect to gender, race, age, or obesity. Cirrhosis was more common in the other types combined (22%) than fatty liver alone (4%; P </= 0.001). Overall mortality, histological iron, and hepatitis C did not differ between groups. Most of the liver-related deaths were in type 4.
Conclusions: The outcome of cirrhosis and liver-related death is not uniform across the spectrum of nonalcoholic fatty liver. These poor outcomes are more frequent in patients in whom biopsies show ballooning degeneration and Mallory hyaline or fibrosis.
Similar articles
- Hepatic iron and nonalcoholic fatty liver disease.
Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparai N, O'Neill R, McCullough AJ. Younossi ZM, et al. Hepatology. 1999 Oct;30(4):847-50. doi: 10.1002/hep.510300407. Hepatology. 1999. PMID: 10498632 - Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.
Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM. Gramlich T, et al. Hum Pathol. 2004 Feb;35(2):196-9. doi: 10.1016/j.humpath.2003.09.018. Hum Pathol. 2004. PMID: 14991537 - The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. Powell EE, et al. Hepatology. 1990 Jan;11(1):74-80. doi: 10.1002/hep.1840110114. Hepatology. 1990. PMID: 2295475 - Nonalcoholic fatty liver disease: a systematic review.
Rinella ME. Rinella ME. JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370. JAMA. 2015. PMID: 26057287 Review. - [Nonalcoholic steatohepatitis: a brief review on its concept].
Ishii H. Ishii H. Nihon Rinsho. 2006 Jun;64(6):1021-4. Nihon Rinsho. 2006. PMID: 16768104 Review. Japanese.
Cited by
- The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study.
Park SH, Park J, Kim H, Lee J, Kwon SY, Lee YB, Kim G, Jin SM, Hur KY, Kim JH. Park SH, et al. Intern Emerg Med. 2024 Sep 5. doi: 10.1007/s11739-024-03758-6. Online ahead of print. Intern Emerg Med. 2024. PMID: 39235708 - Sonic hedgehog expression in steatohepatitic hepatocellular carcinoma and its clinicopathological significance.
Kusano H, Ogasawara S, Omuraya M, Okudaira M, Mizuochi S, Mihara Y, Kinjo Y, Yano Y, Nakayama M, Kondo R, Naito Y, Akiba J, Nakashima O, Yano H. Kusano H, et al. Oncol Lett. 2024 Jul 18;28(3):442. doi: 10.3892/ol.2024.14575. eCollection 2024 Sep. Oncol Lett. 2024. PMID: 39091582 Free PMC article. - Assessment of Metabolic and Bariatric Surgery Safety in Patients with Advanced Liver Fibrosis.
Barum G, Paladini LA, de Oliveira PGS, Moreira TR, Tovo CV, Mattos ÂZ. Barum G, et al. Obes Surg. 2024 Sep;34(9):3173-3180. doi: 10.1007/s11695-024-07434-8. Epub 2024 Jul 30. Obes Surg. 2024. PMID: 39078451 - The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: analysis of the NHANES 2017-2018 cycle.
Alkhouri N, Almomani A, Le P, Payne JY, Asaad I, Polanco P, Leff P, Kumar P, Noureddin M. Alkhouri N, et al. BMC Gastroenterol. 2024 Jul 8;24(1):218. doi: 10.1186/s12876-024-03295-8. BMC Gastroenterol. 2024. PMID: 38977950 Free PMC article. - Envisioning how to advance the MASH field.
Allen AM, Younossi ZM, Diehl AM, Charlton MR, Lazarus JV. Allen AM, et al. Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):726-738. doi: 10.1038/s41575-024-00938-9. Epub 2024 Jun 4. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38834817 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources